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Abstract 
Previous studies have suggested that survival following surgery for colorectal cancer is 
poorer in the elderly.  However, the findings were inconsistent and none of the studies 
adjusted for case mix.  The aim of the present study was to establish whether there were 
age-related differences in cancer (colorectal) specific and non-cancer (colorectal) related 
survival in patients undergoing elective potentially curative resection for Dukes stage A/ B 
colorectal cancer.  One thousand and forty three patients who underwent elective potentially 
curative resection for Dukes’ A/B colorectal cancer between 1991-1994 in 11 hospitals in 
Scotland were included in the study.  Ten year cancer specific and non-cancer related 
survival and the hazard ratios were calculated according to age groups (<64. 65-74/ >74 
years).  On follow-up 273 patients died of their cancer and 328 died of non-cancer related 
causes.  At 10 years overall survival was 45%, cancer specific was 70% and non-cancer 
related survival was 64%.  On multivariate analysis of all factors, age (HR 1.38, 95%CI 
1.18-1.62, p<0.001), sex (HR 1.74, 95%CI 1.36-2.23, p<0.001), site (HR 1.42, 95%CI 1.11-
1.81, p<0.01) and Dukes’ stage (HR 1.71, 1.19-2.47, p<0.01) were independently associated 
with cancer specific survival.  On multivariate analysis of all factors, age (HR 2.14, 1.84-
2.49, p<0.001), sex (HR 1.43, 1.15-1.79, p<0.01) and deprivation (HR 1.30, 1.09-1.55, 
p<0.01) were independently associated with non-cancer related survival.  The results of the 
present study show that increasing age impacts negatively both on cancer specific and non-
cancer related survival following elective potentially curative resection for node negative 
colorectal cancer.  However, the effect of increasing age is greater on the non-cancer related 
survival.  These results suggest that cancer specific and non-cancer related mortality should 
be considered separately in survival analysis of these cancer patients. 
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Introduction 
 Colorectal cancer is the second commonest cause of cancer death in Western Europe 
and North America.  Many patients have evidence of locally advanced or metastatic disease 
at the time of initial presentation.  Even in those undergoing apparently curative resection, 
only half survive 5 years (McArdle and Hole, 2002a).  
 It has long been recognised that there are a number of factors, in addition to 
pathological stage, which contribute to poor outcome following potentially curative surgery 
for colorectal cancer.  Age (Mulcahy et al., 1994; Shankar and Taylor, 1998; Colorectal 
Cancer Collaborative Group, 2000), gender (McArdle et al., 2003), deprivation (Hole and 
McArdle, 2002), tumour site (McArdle and Hole, 2002b), emergency presentation 
(McArdle and Hole, 2004a), and specialisation (McArdle and Hole, 2004b) have been 
shown to impact on long term survival in these patients. 
 However, whether old age is associated with poorer survival, independent of these 
factors, remains unclear.  The aim of the present study was to establish whether there were 
age-related differences in cancer (colorectal) specific and non-cancer (colorectal) related 
survival in patients undergoing elective potentially curative resection for Dukes stage A/ B 
colorectal cancer. 
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Patients and methods 
One thousand and forty three patients who underwent an elective potentially curative 
resection for Dukes A/ B colorectal cancer between 1st January 1991 and 31st December 
1994 in eleven hospitals in the central belt of Scotland were included in the study.  
Information was abstracted from casenotes by two specially trained data managers.  Details 
included age, sex, deprivation category, site of tumour, extent of tumour spread, the nature 
of surgery, post-operative mortality, Dukes’ stage and adjuvant therapy.  Data for 1991 and 
1992 were collected retrospectively, and those for 1993 and 1994 were collected 
prospectively.  There was no difference in baseline characteristics of the patients between 
the two periods. 
The extent of deprivation was defined using the Carstairs Index (Carstairs and 
Morris, 1991), an area-based measure derived from the 1991 census data based on the 
postcode of residents at diagnosis.  Carstairs divides the scores into a seven-point scale 
ranging from most affluent (category 1) to most deprived (category 7).  
Tumours were classified according to site colon or rectum.  The extent of tumour 
spread was assessed by conventional Dukes’ classification based on histological 
examination of the resected specimen.  
 Patients were deemed to have had a curative resection if the surgeon considered that 
there was no macroscopic residual tumour once resection had been completed.   
Individual surgeons were defined as specialists or non-specialists by a panel of six 
senior consultants and one of the authors (C.S.McA.).  Two of the six consultants were 
specialist colorectal surgeons from teaching hospitals and four were district general hospital 
consultants.  These assessments were made without knowledge of the outcome and before 
any analysis was performed. 
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Approval was obtained for information on date and cause of death to be checked 
with that received by the cancer registration system through linkage with the Registrar 
General (Scotland).  Deaths up to the end of 2003 have been included in the analysis, 
providing an average length of follow-up of 11 years (minimum 9 years, maximum 13 
years).   
 
Statistical analysis 
 The percentages of patients surviving 10 years were calculated using the Kaplan-
Meier technique.  Comparison of the association between age and other variables was made 
using the X2 test or a X2 for trend where appropriate.  The effect of age on cancer and non-
cancer related survival was examine using Cox’s proportional hazards model.  Analysis was 
performed using the SPSS software package (SPSS Inc., Chicago, IL, USA). 
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Results 
Of the 1043 patients included in the analysis, 33% were aged 75 or over, 21% were 
socio-economically deprived, 59% had colonic tumours and 82% had Dukes’ B disease at 
the time of surgery.  275 (26%) patients were treated by a specialist surgeon.  Three percent 
of patients received adjuvant therapy.   
The baseline characteristics of the patients included in the study are shown in Table 
1.  With increasing age there was an increase in the proportion of patients who had colonic 
tumours (p<0.001).  Few patients over the age of 74 years received adjuvant therapy 
(p<0.001).   
 273 patients died of their cancer and 328 died of non-cancer related causes (Table 
2).  Of the non-cancer related deaths 212 (65%) patients died of cardiovascular or 
respiratory disease.  At 10 years overall survival was 45%, cancer specific was 70% and 
non-cancer related survival was 64%.  An increased proportion of cancer deaths at 10 years 
was associated with increased Dukes’ stage (p<0.05) and non-specialist surgeons (p<0.10).  
An increased proportion of non-cancer related deaths at 10 years was associated with older 
age (p<0.001), female gender (p<0.05) and deprivation (p<0.10).  
 On univariate analysis, age (p<0.01), sex (p<0.001), site (p<0.05) and Dukes’ stage 
(p<0.01) were significantly associated with cancer specific survival (Table 3).  On 
multivariate analysis of all factors, age (HR 1.38, 95%CI 1.18-1.62, p<0.001), sex (HR 
1.74, 95%CI 1.36-2.23, p<0.001), site (HR 1.42, 95%CI 1.11-1.81, p<0.01) and Dukes’ 
stage (HR 1.71, 1.19-2.47, p<0.01) were independently associated with cancer specific 
survival. 
 On univariate analysis, age (p<0.001), sex (p<0.05), deprivation (p<0.01) and 
adjuvant therapy (p<0.10) were significantly associated with non-cancer related survival 
(Table 4).  On multivariate analysis of all factors, age (HR 2.14, 1.84-2.49, p<0.001), sex 
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(HR 1.43, 1.15-1.79, p<0.01) and deprivation (HR 1.30, 1.09-1.55, p<0.01) were 
independently associated with non-cancer related survival. 
 The relationship between age and the hazard ratios for cancer and non-cancer related 
survival in patients with Dukes’ A/ B disease colon and rectum cancer is shown in Table 5.  
Compared with patients under the age 64years who had colonic tumours, those patients over 
the age of 74years had a hazard ratio of 2.2 (P<0.01) and 5.4 (p<0.001) for cancer and non 
cancer related survival respectively.  Compared with patients under the age 64years who 
had rectal tumours, those patients over the age of 74years had a hazard ratio of 5.1 
(p<0.001) for non cancer related survival. 
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Discussion 
The results of the present study show that, in patients undergoing elective potentially 
curative surgery for Dukes’ A/ B colorectal cancer, with 10-year follow-up, more patients 
die of intercurrent disease, in particular cardiovascular or respiratory disease, than die of 
cancer.  Increasing age, 75years and over, impacted on cancer related and non-cancer 
related survival.  Although, it was notable that the effect on non-cancer related survival was 
approximately twice that of cancer related survival.    
Given that colorectal cancer is a common cancer and that large numbers of patients 
undergoing elective potentially curative resection will die of intercurrent comorbid disease, 
the use of overall survival as an end-point may give misleading results.  Therefore, future 
studies of these patients should specify the associations between factors and cancer specific 
survival and non-cancer related survival separately in order to establish whether the factor 
impacts equally on cancer specific and non-cancer related survival. 
The results of the present study have a number of important implications.  Firstly, 
with the introduction of screening programmes for colorectal cancer and the consequent 
increase in early stage disease it is likely that the issue of age-related comorbid death will 
become a major issue in these patients.   If this were proven to be the case it would be 
important that within screening programmes for colorectal cancer, patients should be also 
screened for the presence of comorbid disease.  For example, in patients aged of 75 years 
and over undergoing potentially curative resection for node negative colorectal cancer, it 
would be important not only to treat the cancer, but also the comorbid disease, in particular 
it would appear from the present study that this is cardiovascular or respiratory disease.   
In the context of the present study it is of interest that a strong association between 
colorectal cancer and vascular disease has been reported (Chan et al., 2006; Chan et al., 
2007).  This may be due to shared environmental risk factors such as age, smoking, diabetes 
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mellitus and obesity (Giovannucci and Martínez, 1996; Larsson et al., 2005; McMillan et 
al., 2006).  It has also been hypothesised that these diseases develop through a common 
pathway of chronic inflammatory disease (Chan et al., 2006; Chan et al., 2007).  Indeed, 
there is evidence that such environmental factors are directly associated with C-reactive 
protein concentrations, the prototypical marker of the systemic inflammatory response, in 
apparently healthy subjects (Koenig et al., 1999; Hutchinson et al., 2000; Chenillot et al., 
2000: Wong et al., 2001).  However, it remains to be determined whether the systemic 
inflammatory response impacts equally on cancer specific and non-cancer related survival 
in patients undergoing potentially curative surgery for colorectal cancer.   
In summary, the results of the present show that although age impacts both on 
cancer specific and non-cancer related survival following elective potentially curative 
resection for node negative colorectal cancer, the effect is greater on non-cancer related 
survival.  These results suggest that cancer specific and non-cancer related deaths should be 
considered separately in survival analysis of these patients. 
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Table 1:  Baseline characteristics of patients undergoing elective curative resection for 
Dukes A/B colorectal cancer by age (n= 1043) 
  Age (years)   
     
 <64yrs 
n= 305 
(29%) 
65-74yrs 
n= 398 
(38%) 
>74 
n= 340 
(33%) 
p value 
     
Female 143 (47%) 186 (47%) 184 (56%)  
Male 162 (53%) 212 (53%) 156 (46%) 0.061 
     
Depcat Score     
   1, 2 53 (17%) 70 (18%) 69 (20%)  
   3, 4, 5 191 (63%) 245 (62%) 201 (59%)  
   6, 7 61 (20%) 83 (21%) 70 (21%) 0.625 
     
Site     
   Colon  160 (52%) 228 (57%) 223 (66%)  
   Rectum 145 (48%) 170 (43%) 117 (37%) <0.001 
     
Dukes’ Stage     
   A 52 (17%) 76 (19%) 56 (17%)  
   B 253 (83%) 322 (81%) 284 (83%) 0.822 
     
Specialisation     
   Specialist 76 (25%) 104 (27%) 95 (28%)  
   Non-specialist 223 (75%) 288 (73%) 240 (72%) 0.402 
     
     
Adjuvant therapy     
   Yes 15 (5%) 16 (4%) 3 (1%)  
   No 290 (95%) 382 (96%) 337 (99%) <0.001 
 
 
  
 13
Table 2:  Baseline characteristics of patients undergoing elective curative resection for 
Dukes A/B colorectal cancer by cancer and non-cancer death after 10 years follow-up 
    
 Cancer deaths 
(n= 273) 
Non-cancer deaths 
(n= 328) 
p value 
Age    
<64yrs 68 (25%) 42 (13%)  
65-74yrs 109 (40%) 129 (39%)  
>74yrs 96 (35%) 157 (48%) <0.001 
    
Female 104 (38%) 153 (47%)  
Male 169 (62%) 175 (53%) 0.035 
    
Depcat Score    
   1, 2 53 (19%) 45 (14%)  
   3, 4, 5 167 (62%) 206 (63%)  
   6, 7 53 (19%) 77 (24%) 0.052 
    
Site    
   Colon 148 (54%) 192 (59%)  
   Rectum 125 (46%) 136 (41%) 0.287 
    
Dukes’ Stage    
   A 34 (13%) 61 (19%)  
   B 239 (87%) 267 (81%) 0.040 
    
Specialisation    
   Specialist 61 (23%) 94 (27%)  
   Non-specialist 209 (77%) 226 (71%) 0.062 
    
Adjuvant therapy    
   Yes 10 (4%) 6 (2%)  
   No 263 (96%) 322 (98%) 0.165 
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Table 3.  The relationship between clinicopathological characteristics and cancer specific 
survival in patients undergoing elective curative resection for Dukes A/B colorectal cancer: 
Univariate and multivariate analysis. 
 
  Univariate analysis  Multivariate analysis  
 Patients 
(n= 1043) 
Hazard ratio 
(95% CI) 
P-value Hazard ratio 
(95% CI) 
P-value 
Age (<64/ 65-74/ >74years) 305/ 398/ 340 1.29 (1.11-1.50) 0.001 1.38 (1.18-1.62) <0.001 
Sex (female/ male) 513/ 530 1.75 (1.37-2.23) <0.001 1.74 (1.36-2.23) <0.001 
Deprivation (1-2/ 3-5/ 6-7)* 192/ 637/ 214 0.98 (0.81-1.19) 0.840  0.322 
Site (colon/ rectum) 611/ 432 1.28 (1.01-1.62) 0.044 1.42 (1.11-1.81) 0.006 
Dukes’ stage (A/ B) 184/ 859 1.70 (1.19-2.44) 0.004 1.71 (1.19-2.47) 0.004 
Specialisation (yes/ no) 275/ 751 1.27 (0.95-1.69) 0.101  0.104 
Adjuvant therapy (yes/ no) 34/ 1009 0.94 (0.50-1.77) 0.845  0.750 
      
*  Individual deprivation categories were used in the statistical analysis 
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Table 4.  The relationship between clinicopathological characteristics and non-cancer 
survival in patients undergoing elective curative resection for Dukes A/B colorectal cancer: 
Univariate and multivariate analysis. 
 
  Univariate analysis  Multivariate analysis  
 Patients 
(n= 1043) 
Hazard ratio 
(95% CI) 
P-value Hazard ratio 
(95% CI) 
P-value 
Age (<64/ 65-74/ >74years) 305/ 398/ 340 2.11 (1.82-2.45) <0.001 2.14 (1.84-2.49) <0.001 
Sex (female/ male) 513/ 530 1.32 (1.06-1.64) 0.012 1.43 (1.15-1.79) 0.002 
Deprivation (1-2/ 3-5/ 6-7)* 192/ 637/ 214 1.30 (1.09-1.53) 0.003 1.30 (1.09-1.55) 0.003 
Site (colon/ rectum) 611/ 432 1.11 (0.88-1.37) 0.407  0.094 
Dukes’ stage (A/ B) 184/ 859 1.07 (0.81-1.42) 0.676  0.346 
Specialisation (yes/ no) 275/ 751 0.89 (0.70-1.13) 0.332  0.548 
Adjuvant therapy (yes/ no) 34/ 1009 2.11 (0.96-4.87) 0.061  0.302 
      
*  Individual deprivation categories were used in the statistical analysis 
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Table 5:  Hazard ratios for cancer specific and non-cancer survival at 10 years in patients 
undergoing elective curative resection for Dukes A/B colorectal cancer by age. 
 
Colon 
(n= 611) 
Cancer specific 
(deaths= 148) 
 Non-cancer 
(deaths= 192) 
 
 Hazard ratio (95%CI) p-value Hazard ratio (95%CI) p-value 
Age  <64yrs 1 0.004 1 <0.001 
        65-74yrs 1.71 (1.09-2.69) 0.019 3.01 (1.85-4.91) <0.001 
        >74yrs 2.16 (1.38-3.37) 0.001 5.39 (3.36-8.64) <0.001 
     
Rectum 
(n= 432) 
Cancer specific 
(deaths= 125) 
 Non-cancer 
(deaths= 136) 
 
 Hazard ratio (95%CI) p-value Hazard ratio (95%CI) p-value 
Age  <64yrs 1 0.286 1 <0.001 
        65-74yrs 1.28 (0.85-1.94) 0.237 3.02 (1.84-4.50) <0.001 
        >74yrs 1.42 (0.90-2.25) 0.132 5.09 (3.08-8.41) <0.001 
 
  
